Combined Use of cyclinD1 and Ki67 for Prognosis of Luminal-Like Breast Cancer Patients

par Junmei Hao, Wenfeng Zhang, Yan Lyu, Jiarui Zou, Yunyun Zhang, Jiahong Lyu, Jianbo Zhang, Shuishan Xie, Cuiping Zhang, Jiandi Zhang, Fangrong Tang
Publié 2021

The Pseudokinase TRIB3 Negatively Regulates the HER2 Receptor Pathway and Is a Biomarker of Good Prognosis in Luminal Breast Cancer

par Alba Orea-Soufi, Sonia Castillo-Lluva, Nélida Salvador-Tormo, Paola Martín-Cabrera, Silvia Recuero, Estíbaliz Gabicagogeascoa, Manuel Moreno-Valladares, Marina Mendiburu-Eliçabe, Adrián Blanco-Gómez, José Miguel Ramos-Pittol, Elena García-Taboada, Alberto Ocaña, Francisco J. Cimas, Ander Matheu, Isabel Álvarez-López, Guillermo Velasco, Mar Lorente
Publié 2021

Negative progesterone receptor status correlates with increased risk of breast cancer recurrence in luminal B HER2-positive and -negative subtypes

par Toshiaki Utsumi, Naomi Kobayashi, Masahiro Hikichi, Kaori Ushimado, Makoto Kuroda
Publié 2021

Breast cancer immunophenotype and its relationship with haematopoiesis

par Denis A. Ryabchikov, Svetlana V. Chulkova, Farhad A. Shamilov, Nail V. Chanturia, Sergey D. Zheltikov, Nikolai N. Tupitsyn
Publié 2021

Preparation of Eu_0.075Tb_0.925-Metal Organic Framework as a Fluorescent Probe and Application in the Detection of Fe³⁺ and Cr₂O<sub>7</su...

par Jie Yin, Hongtao Chu, Shili Qin, Haiyan Qi, Minggang Hu
Publié 2021

Positive Regulation of Estrogen Receptor Alpha in Breast Tumorigenesis

par Lucas Porras, Houssam Ismail, Sylvie Mader
Publié 2021